An Exploratory Study of the Safety and Efficacy of a Trigonella foenum-graecum Seed Extract in Early Glucose Dysregulation: A Double-Blind Randomized Placebo-Controlled Trial

被引:7
|
作者
Pickering, Emily [1 ,2 ]
Steels, Elizabeth [1 ,2 ]
Rao, Amanda [3 ]
Steadman, Kathryn J. [1 ]
机构
[1] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia
[2] Evidence Sci Pty Ltd, Brisbane, Qld 4005, Australia
[3] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld 4102, Australia
关键词
Trigonella foenum-graecum; fenugreek; prediabetes; type; 2; diabetes; fasting blood glucose; post-prandial glucose; insulin; FENUGREEK SEEDS; INSULIN-RESISTANCE; BLOOD-GLUCOSE; TYPE-2; L; 4-HYDROXYISOLEUCINE; HYPERGLYCEMIA; STRESS;
D O I
10.3390/pharmaceutics14112453
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: This was an exploratory study to assess the safety and efficacy of a specialized Trigonella foenum-graceum L. seed extract for supporting healthy blood glucose metabolism in a pre-diabetic cohort. Methods: Fifty-four participants were randomised to receive 500 mg/day of T. foenum-graecum seed extract or matching placebo daily for 12 weeks. Fasting blood glucose (FBG), post-prandial glucose (PPBG), HbA1c, fasting insulin (FI), post-prandial insulin (PPI) and C-peptide were assessed at baseline, week 6 and week 12. Lipid levels, liver enzymes and C-reactive protein (CRP), along with safety markers and tolerability were also assessed at baseline and week 12. Results: By week 12 there was a significant difference in FBG (p < 0.001), PPBG (p = 0.007) and triglycerides (p = 0.030) between treatment groups, with no changes in HbA1c (p = 0.41), FI (p = 0.12), PPI (p = 0.50) or C-peptide (p = 0.80). There was no difference in total cholesterol (p = 0.99), high-density lipoprotein (p = 0.35), low density lipoprotein (p = 0.60) or CRP (p = 0.79). There was no change in safety markers and the treatment was well tolerated. Conclusions: The results of the study indicated that T. foenum-graecum seed extract may influence blood glucose metabolism and larger studies are warranted to evaluate efficacy and potential mechanisms of action.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The efficacy and safety of Codonopsis lanceolata water extract for sarcopenia: A study protocol for randomized, double-blind, placebo-controlled clinical trial
    Park, Jaehyeon
    Kim, Hyungsuk
    Choung, Se-Young
    Jeon, Yong Jae
    Jeon, Hyo Jin
    Youn, Sang Jun
    Choi, Yong
    Cho, Hong-Seok
    Kang, Junhyuk
    Seo, Yeonho
    Kim, Koh-Woon
    Song, Mi-Yeon
    MEDICINE, 2022, 101 (39) : E30773
  • [22] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [23] Efficacy and safety of Sophora alopecuroides var. alopecuroides seed extract for opioid detoxification: A randomized, double-blind, and placebo-controlled clinical trial
    Kianbakht, Saeed
    Hajiaghaee, Reza
    Akhondzadeh, Shahin
    PHYTOTHERAPY RESEARCH, 2020, 34 (05) : 1108 - 1113
  • [24] Efficacy and Safety of Pueraria lobata Extract in Gray Hair Prevention: A Randomized, Double-Blind, Placebo-Controlled Study
    Jo, Seong Jin
    Shin, Hyoseung
    Paik, Seung Hwan
    Na, Sun Jae
    Jin, Yingji
    Park, Won Seok
    Kim, Su Na
    Kwon, Oh Sang
    ANNALS OF DERMATOLOGY, 2013, 25 (02) : 218 - 222
  • [25] Efficacy and Safety of the Cudrania tricuspidata Extract on Functional Dyspepsia: A Randomized Double-Blind Placebo-Controlled Multicenter Study
    Shin, Jinyoung
    Oh, Tae-Hoon
    Kim, Joo-Yun
    Shim, Jae-Jung
    Lee, Jung-Lyoul
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [26] Efficacy and safety of human placenta extract in alleviating climacteric symptoms: Prospective, randomized, double-blind, placebo-controlled trial
    Lee, Yoo-Kyung
    Chung, Hyun Hoon
    Kang, Soon-Beom
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2009, 35 (06) : 1096 - 1101
  • [27] Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study
    Mollace, Rocco
    Gliozzi, Micaela
    Macri, Roberta
    Tavernese, Annamaria
    Musolino, Vincenzo
    Carresi, Cristina
    Maiuolo, Jessica
    Muscoli, Carolina
    Tomino, Carlo
    Rosano, Giuseppe Maria
    Fini, Massimo
    Volterrani, Maurizio
    Silvestrini, Bruno
    Mollace, Vincenzo
    PHARMACEUTICS, 2022, 14 (01)
  • [28] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
  • [29] Efficacy and Safety of Vilazodone in Generalized Anxiety Disorder: A Randomized, Double-blind, Placebo-controlled Trial
    Thase, Michael E.
    Mathews, Maju
    Forero, Giovanna
    Nunez, Rene
    Chen, Changzheng
    Gommoll, Carl
    Durgam, Suresh
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S344 - S344
  • [30] Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial
    Ashrafi, Mahmoud Reza
    Salehi, Soodeh
    Malamiri, Reza Azizi
    Heidari, Morteza
    Hosseini, Seyed Ahmad
    Samiei, Mahboubeh
    Tavasoli, Ali Reza
    Togha, Mansoureh
    PEDIATRIC NEUROLOGY, 2014, 51 (04) : 503 - 508